ViiV Healthcare announced positive headline results from its global, phase III ATLAS study of a long-acting, injectable two-drug regimen (2DR)...
Ziylo and Novo Nordisk A/S announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of...
Bristol-Myers Squibb Company announced that Opdivo (nivolumab) received approval from the U.S. FDA as the first and only Immuno-Oncology treatment...
Healthy Interactions, a global leader in health education, in collaboration with Merck , known as MSD outside the United States...
Eisai Inc. and Merck , known as MSD outside of the United States and Canada , announced that the U.S....
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this...
Bayer and Haplogen GmbH, a Vienna-based biotechnology company, have entered into a multi-year research collaboration agreement to identify new drug...
In a milestone transaction, a major pharmaceutical company based in China will undertake a multisite clinical study using TrialMaster EDC...
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, announced...
Teva Pharmaceutical Industries Ltd. and Regeneron Pharmaceuticals, Inc. announced positive topline results from a Phase 3, randomized, double-blind, placebo-controlled study...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
